FDA 483 - Rakshit Drugs Private Limited - November 22, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Rakshit Drugs Private Limited in Anakapalli, India, an API and intermediate manufacturer, revealed significant deficiencies in quality control. Observations included inadequate equipment cleaning procedures, insufficient equipment qualification, flawed out-of-specification investigations, and unsecured computerized system data backups. Additionally, improper microbiological water quality analysis was noted, indicating systemic issues in ensuring product quality and data integrity.
ID · 00973d3f-5378-43ec-bda4-4258badebbce